Works matching IS 1021335X AND DT 2022 AND VI 47 AND IP 2
Results: 21
Suppression of CDCA3 inhibits prostate cancer progression via NF-κB/cyclin D1 signaling inactivation and p21 accumulation.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Inhibition of triple-negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Lysosome-targeted drug combination induces multiple organelle dysfunctions and non-canonical death in pancreatic cancer cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Decursin inhibits tumor progression in head and neck squamous cell carcinoma by downregulating CXCR7 expression in vitro.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Systematic characterization of the tumor microenvironment in Chinese patients with hepatocellular carcinoma highlights intratumoral B cells as a potential immunotherapy target.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Methylation and mutation of the inhibin-α gene in human melanoma cells and regulation of PTEN expression and AKT/PI3K signaling by a demethylating agent.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Anti-VEGF antibody triggers the effect of anti-PD-L1 antibody in PD-L1<sup>low</sup> and immune desert-like mouse tumors.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Siah1 in cancer and nervous system diseases.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Role of MRI-based radiomics in locally advanced rectal cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Mitochondrial DNA mutations are involved in the acquisition of cisplatin resistance in human lung cancer A549 cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Methionine aminopeptidase-2 is a pivotal regulator of vasculogenic mimicry.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Niclosamide suppresses T-cell acute lymphoblastic leukemia growth through activation of apoptosis and autophagy.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β-catenin pathway.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Long intergenic non-protein coding RNA 152 promotes multiple myeloma progression by negatively regulating microRNA-497.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Function and transcriptional regulation of TCTN1 in oral squamous cell carcinoma.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Synergistic effects of co-expression plasmid-based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article